NDC 67457-662
TOPOTECAN
Topotecan
TOPOTECAN is a Intravenous Injection, Solution, Concentrate in the Human Prescription Drug category. It is labeled and distributed by Mylan Institutional Llc. The primary component is Topotecan Hydrochloride.
| Product ID | 67457-662_0cd4acf2-b424-4a8a-8e82-e842a46b387a |
| NDC | 67457-662 |
| Product Type | Human Prescription Drug |
| Proprietary Name | TOPOTECAN |
| Generic Name | Topotecan |
| Dosage Form | Injection, Solution, Concentrate |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2018-04-09 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA206074 |
| Labeler Name | Mylan Institutional LLC |
| Substance Name | TOPOTECAN HYDROCHLORIDE |
| Active Ingredient Strength | 1 mg/mL |
| Pharm Classes | Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |